Litigation Details for Novo Nordisk Inc. v. Zydus Worldwide DMCC (D. Del. 2022)
✉ Email this page to a colleague
Novo Nordisk Inc. v. Zydus Worldwide DMCC (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-03-04 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 10,335,462; 9,132,239 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novo Nordisk Inc. v. Zydus Worldwide DMCC
Biologic Drugs cited in Novo Nordisk Inc. v. Zydus Worldwide DMCC
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Novo Nordisk Inc. v. Zydus Worldwide DMCC (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-03-03 | 3 | ANDA Form | Expiration of Patent: U.S. Patent No. 9,132,239 expires 2/1/2032 and U.S. Patent No. 10,335,462 expires on… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 4 March 2022 1:22-cv-00297 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-03-03 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2 ;10,335,462 B2. (srs) (… 4 March 2022 1:22-cv-00297 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |